482305-94-2

Basic information

• Product Name: tert-Butyl 4-[(3-{[(5-chloro-thien-2-yl)carbonyl]amino}-2-hydroxypropyl)amino]-phenyl-carbamate
• CAS NO: 482305-94-2
• Molecular Weight: 425.936
• Mol File: 482305-94-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: tert-Butyl 4-[(3-{[(5-chloro-thien-2-yl)carbonyl]amino}-2-hydroxypropyl)amino]-phenyl-carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl 4-[(3-{[(5-chloro-thien-2-yl)carbonyl]amino}-2-hydroxypropyl)amino]-phenyl-carbamate(482305-94-2)
• EPA Substance Registry System: tert-Butyl 4-[(3-{[(5-chloro-thien-2-yl)carbonyl]amino}-2-hydroxypropyl)amino]-phenyl-carbamate(482305-94-2)

Safety Data

• Hazardous Substances Data: 482305-94-2(Hazardous Substances Data)

Upstream product

• 71026-66-9 N-(tert-butoxycarbonyl)-1,4-phenylenediamine 

Relevant articles and documents

MICROANGIOPATHY TREATMENT AND PREVENTION

The present invention relates to the use of selective factor Xa inhibitors, in particular of oxazolidinones of the formula (I) for the treatment and/or prophylaxis of microangiopathies and also their use for the production of medicaments for the treatment and/or prophylaxis of microangiopathies.

Combination Therapy Comprising Substituted Oxazolidinones for the Prevention and Treatment of Cerebral Circulatory Disorders

The present invention relates to combinations of A) oxazolidinones of the formula (I), with B) antiarrhythmics, processes for the production of these combinations, their use for the prophylaxis and/or treatment of diseases, and their use for the manufacture of medicaments for the prophylaxis and/or treatment of diseases, especially of thromboembolic disorders and/or complications.